<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN" >
<html>
<head>
<title>Osmium Tetroxide</title>
<style type="text/css">
<!-- #fnt  {font-family:verdana, arial, helvetica; font-size:9pt;}-->
</style>

<meta name="generator" content="WINPLT">
<!--Generated by PLT: https://www.chem.wisc.edu/areas/reich/plt/winplt.htm-->
<!--Source PLT file: e:\_Wp\Courses\_547\_chem547-2-redox-v19.plt-->
<meta name="author" content="">
<meta name="description" content=""><meta name="keywords" content="">

</head>
<body text="#000000" bgcolor="#FFFFFF">

<basefont face="Arial">
<!--========== Start of Table ====-->
<table>
<tr>
<td width=3%> </td><td width=94%>
<div id="fnt">
<p><b><span style="font-size:12pt; color:#B6120A;">Osmium Tetroxide</span></b></p>
<p><i>Osmium tetraoxide cis hydroxylation of unsaturated substrates</i><br>
&nbsp;&nbsp; Schroeder, M. <i>Chem. Rev.</i> <b>1980</b>, <i>80</i>, 187-213<br>
<i>Recent Advances in the Asymmetric Dihydroxylation of Alkenes,</i><br>
&nbsp;&nbsp; Lohray, B. B. <i>Tetrahedron: Asymmetry</i> <b>1992</b>, <i>3</i>, 1317.  <br>
<i>Catalytic Asymmetric Dihydroxylation,</i><br>
&nbsp;&nbsp; Kolb, H.C.; VanNieuwenhze, M. S.; Sharpless, K. B. <i>Chem. Rev.</i>, <b>1994</b>, <i>94</i>, 2483-547. <br>
<i>Sharpless Asymmetric Aminohydroxylation: Scope, Limitations, and Use in Synthesis,</i><br>
&nbsp;&nbsp; O'Brien, P. <i>Angew. Chem. Int. Ed. Engl.</i> <b>1999</b>, <i>38</i>, 326-9. <br>
<i>Development of the Directed Dihydroxylation Reaction,</i><br>
&nbsp;&nbsp; Donohoe, T. J. <i>Synlett</i> <b>2002</b>, 1223-32. Nilov, D.; Reiser, O. <br>
<i>The Sharpless Asymmetric Aminohydroxylation-Scope and Limitation,</i><br>
&nbsp;&nbsp; <i>Advanced Synthesis and Catalysis</i> <b>2002</b>, <i>344</i>, 1169-73. <br>
<i>The Sharpless Asymmetric Aminohydroxylation,</i><br>
&nbsp;&nbsp; Bodkin, J. A.; McLeod, M. D. <i>J. C. S. Perkin I </i> <b>2002</b>, 2733-46. <br>
<i>Imido-Osmium(VIII) Compounds in Organic Synthesis: Aminohydroxylation and Diamination Reactions,</i><br>
&nbsp;&nbsp; Muniz, K. <i>Chem. Soc, Rev.</i>  <b>2004</b>, <i>33</i>, 166-74.89.<br>
<i>The Development of Asymmetric Diamination of Alkenes with Imido-Osmium Reagents</i><br>
&nbsp;&nbsp;Muniz, K. <i>New J. Chemistry</i>. <b>2005</b>, <i>29</i>, 1371-85. <br>
<i>Asymmetric Dihydroxylation of Alkenes&#183;<br>
&nbsp;&nbsp;Noe, M. C.; Letavic, M. A.; Snow, S. L.; McCombie, S. W. <i>Organic Reactions</i> <b>2005</b>, <i>66</i>, 109.</p>

<img src="2-redox{28-00}.gif">&nbsp;

<p>&nbsp;&nbsp;The OsO<sub>4</sub> cis-hydroxylation of alkenes directly introduces vicinal hydroxy groups, and this may be the ultimate goal (as in the synthesis of Sativenediol below).  However many other subsequent transformations of the diol lead to other functionalities.  The most common is C-C bond cleavage of the diol with NaIO<sub>4</sub> or Pb(OAc)<sub>4</sub> to give aldehydes or ketones (Anatoxin), but many other transformations can be performed, such as Peterson olefination (Conduritol), reduction to mono alcohol (Adaline), oxidation to &alpha;-hydroxy ketones or &alpha;-diketones (Cephalotaxine).</p>
<p>&nbsp;&nbsp;For most applications OsO<sub>4</sub> is too expensive and toxic to use stoichiometrically, so it is usually used catalytically together with a stoichiometric oxidant, most commonly an amine oxide (N-methylmorpholine N-oxide (NMO) or trimethylamine oxide).   If the goal is to cleave the double bond (and this is the most common use of OsO<sub>4</sub>), then sodium or potassium periodate is used, it functions as both reoxidant and diol cleavage agent.</p>
<p><b>Sativenediol</b>: Sigrist, R.; Rey, M.; Dreiding, A. <i>Helv. Chem. Acta</i> <b>1988</b>, <i>71</i>, 788. <a href="http://dx.doi.org/10.1002/hlca.19880710414">DOI</a></p>

<a href="../syntheses/sativendiol-dreiding.htm"><img src="2-redox{28-01}.gif" border="1"></a>&nbsp;

<p><b>Anatoxin A</b>: Brenneman, G. B.; Martin, S. F.  <i>Org. Lett</i>.  <b>2004</b>, <i>6</i>, 1329</p>

<a href="../syntheses/anatoxin-a-martin.htm"><img src="2-redox{28-02}.gif" border="1"></a>&nbsp;

<p>&nbsp;&nbsp;In the example below a bis-hydroxylation followed by reductive removal of one of the OH groups is equivalent to a regio- and stereo-selective hydration of the double bond. <b>Adaline</b>: Itoh, T.; Yamazaki, N.; Kibayashi, C. <i>Org. Lett.</i> <b>2002</b>, <i>4</i>, 2469.  <a href="http://dx.doi.org/10.1021/ol0200807">DOI</a></p>

<a href="../syntheses/adaline-itoh.htm"><img src="2-redox{28-03}.gif" border="1"></a>&nbsp;

<p><b>Conduritol B, F</b>: Heo, J. N.; Holson, E. B.; Roush, W. R. <i>Org. Lett.</i> <b>2003</b>, <i>5</i>, 1697-1700</p>
<br>
<a href="../syntheses/conduritol-roush.htm"><img src="2-redox{28-04}.gif" border="1"></a>&nbsp;

<p><b>Cephalotaxine</b>: Isono, N,; Mori, M. <i>J. Org. Chem.</i> <b>1995</b>, <i>60</i>, 115-119</p>

<a href="../syntheses/cephalotaxine-mori.htm"><img src="2-redox{28-05}.gif" border="1"></a>&nbsp;

<p><b>Warburganal</b>: Wender. P. A.; Eck, S. L  <i>Tetrahedron Lett.</i> <b>1982</b>, <i>23</i>, 1871. <a href="http://dx.doi.org/10.1016/S0040-4039(00)87207-X">DOI</a></p>
<br>
<a href="../syntheses/warburganal-wender.htm"><img src="2-redox{28-06}.gif" border="1"></a>&nbsp;

</div>
<!--========== Bottom stuff ====-->
<div id="fnt">
<hr>
&#169; 2019 Hans J. Reich, All Rights Reserved
<hr>
<font face="Verdana" size="1" color="#CC0000">
Web page created by <a href = "http://www.chem.wisc.edu/areas/reich/plt/winplt.htm" target="_top">WINPLT</a>. </font>
<!--==========Last Modified Code====-->
<SCRIPT LANGUAGE="JavaScript">
    <!--
    document.write( "<I>Last updated "+ document.lastModified +"</I>");
    -->
</SCRIPT>
</div>
<!--========== Bottom of Table ====-->
</td><td width =3%> </td>
</tr>
</table
</body>
</html>